South Africa: Tests on "HIV Pill" to Stave Off AIDS
July 24, 2008
On Tuesday in Cape Town, the Desmond Tutu HIV Foundation announced plans to test whether a pill provides protection from HIV for men at high risk of contracting the virus. Project Manager Earl Burrell said the pre-exposure prophylaxis strategy -- in which persons are given drugs to help them fight infection -- is already being employed against TB and malaria.
All participants will receive intensive counseling and monthly testing during the two-year study and for a six-month follow-up period. Half the volunteers will receive a daily dose of Truvada -- which combines the antiretrovirals tenofovir and emtricitabine -- while the other half will receive a placebo. Neither the volunteers nor the researchers will know which participants are receiving the HIV medication.
Burrell said Truvada was chosen because it is safe, effective, and has few side effects.
Business Day (South Africa)
07.23.2008; Tamar Kahn
Kaiser Family Foundation Releases New, Updated Resources on HIV/AIDS Reporting; Journal AIDS Releases Special Issue
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.